Barrow, Hanley, Mewhinney & Strauss’s LivaNova LIVN Stock Holding History
Bought
Maintained
Sold
Other funds holding LIVN
Barrow, Hanley, Mewhinney & Strauss's LIVN Position: Q3 2025 in Review
Barrow, Hanley, Mewhinney & Strauss sold out of LivaNova (LIVN) in Q3 2025, closing a stake of 308 shares — an estimated $13.9K sold.
Barrow, Hanley, Mewhinney & Strauss first reported a position in LIVN in Q2 2020 and held it in 21 quarters. The position peaked at $187M in Q2 2021. 271 funds tracked by Wall St. Rank hold LIVN as of Q3 2025.
- Barrow, Hanley, Mewhinney & Strauss reported no remaining LivaNova position as of Q3 2025 after selling out during the quarter.
- Barrow, Hanley, Mewhinney & Strauss sold 308 LivaNova shares in Q3 2025, an estimated $13.9K.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in LivaNova in Q2 2020 and held it in 21 quarters.
- Barrow, Hanley, Mewhinney & Strauss's LivaNova position peaked at $187M in Q2 2021.
- 271 funds tracked by Wall St. Rank held LivaNova as of Q3 2025.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q3 2025, filed 13 Nov 2025.